UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unveiling the role of KRAS in tumor immune microenvironment

Biomedicine & pharmacotherapy, 2024-02, Vol.171, p.116058-116058, Article 116058

2024

Volltextzugriff (PDF)

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

Journal of experimental & clinical cancer research, 2024-01, Vol.43 (1), p.8-8, Article 8

2024

Volltextzugriff (PDF)

Gastric cancer‐derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier

FEBS letters, 2017-07, Vol.591 (14), p.2167-2179

2017

Volltextzugriff (PDF)

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights

Molecular cancer, 2017-01, Vol.16 (1), p.6-6, Article 6

2017

Volltextzugriff (PDF)

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report

BMC cancer, 2019-07, Vol.19 (1), p.702-6, Article 702

2019

Volltextzugriff (PDF)

Correction: Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

Journal of experimental & clinical cancer research, 2024-01, Vol.43 (1), p.21-21, Article 21

2024

Volltextzugriff (PDF)

5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients

Frontiers in oncology, 2020-04, Vol.10, p.492-492

2020

Volltextzugriff (PDF)

Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation

Frontiers in oncology, 2020-07, Vol.10, p.1126-1126

2020

Volltextzugriff (PDF)

E3 ubiquitin ligases Cbl‐b and c‐Cbl downregulate PD‐L1 in EGFR wild‐type non‐small cell lung cancer

FEBS letters, 2018-02, Vol.592 (4), p.621-630

2018

Volltextzugriff (PDF)

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

BMC cancer, 2021-12, Vol.21 (1), p.1324-1324, Article 1324

2021

Volltextzugriff (PDF)

Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation

Frontiers in pharmacology, 2022-08, Vol.13

2022

Volltextzugriff (PDF)

Efficacy and safety of first-line treatments for advanced hepatocellular carcinoma patients: a systematic review and network meta-analysis

Frontiers in immunology, 2024-09, Vol.15

2024

Volltextzugriff (PDF)

PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis

BMC cancer, 2023-12, Vol.23 (1), p.1221-1221, Article 1221

2023

Volltextzugriff (PDF)

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

BMC cancer, 2018-04, Vol.18 (1), p.462-462, Article 462

2018

Volltextzugriff (PDF)

PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis

Frontiers in immunology, 2022-08, Vol.13, p.905651-905651

2022

Volltextzugriff (PDF)

Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis

Experimental cell research, 2018-07, Vol.368 (2), p.194-201

2018

Volltextzugriff (PDF)

Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment

Frontiers in oncology, 2022-01, Vol.11, p.827294-827294

2022

Volltextzugriff (PDF)

β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis

BMC cancer, 2011-05, Vol.11 (1), p.183-183, Article 183

2011

Volltextzugriff (PDF)

Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study

Cancer Immunology, Immunotherapy, 2022-06, Vol.71 (6), p.1443-1451

2022

Volltextzugriff (PDF)

Case report: A case of rare metastasis of gastric cancer to the axillary lymph node metastasis treated with combination immunotherapy

Frontiers in immunology, 2024-02, Vol.15, p.1331506

2024

Volltextzugriff (PDF)

Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China

BMC cancer, 2024-01, Vol.24 (1), p.22-22, Article 22

2024

Volltextzugriff (PDF)

Phase III trials of standard chemotherapy with or without bevacizumab for ovarian cancer: a meta-analysis

PloS one, 2013-12, Vol.8 (12), p.e81858

2013

Volltextzugriff (PDF)

MiR-940 promotes the proliferation and migration of gastric cancer cells through up-regulation of programmed death ligand-1 expression

Experimental cell research, 2018-12, Vol.373 (1-2), p.180-187

2018

Volltextzugriff (PDF)

Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway

Journal of experimental & clinical cancer research, 2020-10, Vol.39 (1), p.1-221, Article 221

2020

Volltextzugriff (PDF)

N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1

Frontiers in oncology, 2021-07, Vol.11, p.681280-681280

2021

Volltextzugriff (PDF)

1 – 25 von 398

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(337)
Mit Volltextzugriff
(364)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Unveiling the role of KRAS in tumor immune microenvironment

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

Gastric cancer‐derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report

Correction: Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients

Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation

E3 ubiquitin ligases Cbl‐b and c‐Cbl downregulate PD‐L1 in EGFR wild‐type non‐small cell lung cancer

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature

Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation

Efficacy and safety of first-line treatments for advanced hepatocellular carcinoma patients: a systematic review and network meta-analysis

PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

PD-1 inhibitors plus oxaliplatin or cisplatin-based chemotherapy in first-line treatments for advanced gastric cancer: A network meta-analysis

Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis

Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment

β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis

Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study

Case report: A case of rare metastasis of gastric cancer to the axillary lymph node metastasis treated with combination immunotherapy

Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China

Phase III trials of standard chemotherapy with or without bevacizumab for ovarian cancer: a meta-analysis

MiR-940 promotes the proliferation and migration of gastric cancer cells through up-regulation of programmed death ligand-1 expression

Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway

N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1

Suchergebnisse filtern